Technology for rapid detection and quantification of volatile organic compounds (VOCs) using breath samples

By using heating elements and mass spectrometer or terahertz spectrometer technology in the respiratory analysis system, the problem of the inability to quickly and accurately detect Δ-9-THC in the prior art is solved, and efficient quantitative analysis is achieved on-site, avoiding CBD misjudgment and other compounds are ignored, improving the reliability and accuracy of detection.

CN112533532BActive Publication Date: 2024-11-19UNIVERSITY OF NORTH TEXAS +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN201980050883.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2018-07-31
Filing Date
2019-07-29
Publication Date
2024-11-19
Estimated Expiration
2039-07-29

AI Technical Summary

Technical Problem

Existing respiratory analysis techniques cannot quickly and accurately detect the concentration of Δ-9-THC on site, and there are problems of misjudgment of CBD and neglecting other compounds, making it difficult to effectively distinguish tobacco smoke from marijuana smoke, affecting justice and safety.

Method used

Using an exemplary respiratory analysis system, including a sampling chamber, a molecular collector and an analysis device, the thermally desorbed volatile organic compounds are introduced through the heating element and the target compounds are identified and quantified using a mass spectrometer or terahertz spectrometer, such as Δ- 9-THC.

Benefits of technology

It realizes rapid and accurate detection of Δ-9-THC concentration in respiratory samples within a few seconds, distinguishing Δ-9-THC from CBD, reducing misjudgment of other compounds, and improving the reliability and accuracy of on-site detection .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN112533532B_ABST
    Figure CN112533532B_ABST
Patent Text Reader

Abstract

An exemplary breath analysis system may include a sampling chamber in which a molecular collector is disposed. The molecular detector may be configured such that volatile organic compounds (VOCs) present in a breath sample introduced into the sampling chamber adhere to the molecular collector. A heating element may introduce heat into the sampling chamber, thereby releasing at least a portion of the VOCs attached to the molecular collector. An analysis device (e.g., a mass spectrometer or a terahertz (THz) spectrometer) may identify one or more target VOCs from at least a portion of the VOCs released by the molecular collector and generate an output representing the identified one or more target VOCs. The output may include information quantifying the concentration of the one or more target VOCs relative to the source of the breath sample.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims the benefit of priority to U.S. Provisional Patent Application No. 62 / 712,941, filed on July 31, 2018, which is incorporated herein by reference in its entirety. Technical Field

[0003] The present application relates to breathalyzer systems and devices. More specifically, the present application relates to breathalyzer systems and devices designed to facilitate on-site quantitative analysis of THC and other substances using breath samples. Background Art

[0004] The legalization of marijuana has caused many judicial problems and raised concerns about civilian safety. Daily marijuana users have increased from 9.8% of the U.S. population in 2007 to 13.39% in 2014. Although it has only increased by 3.6%, the potency of the psychoactive substance Δ-9-tetrahydrocannabinol (Δ-9-THC) in marijuana has also increased from 5% in 2001 to more than 20% in marijuana leaves and more than 60% in crude extracts. The increase in potency has led to an increase in crime reports in the local population. Specifically, in all states with marijuana dispensaries, the property crime rate in areas with a high density of marijuana dispensaries is higher. Another problem with the legalization of marijuana is the influence of marijuana while driving a car. Marijuana users are 25% more likely to have a car accident than sober drivers, and more than 10% of all drivers on weekends are under the influence of illegal drugs. As marijuana is legalized in more states, it is necessary to correctly quantify Δ-9-THC so that people can accurately and quickly determine whether they are under the influence of marijuana. It would also be helpful for the jurisdiction to have a device that can accurately determine concentrations, thereby allowing for the establishment of limits for delta-9-THC for operating a vehicle.

[0005] Currently three cannabinoid compounds are analyzed to determine cannabinoid concentrations in the blood; they are delta-9-THC, 11-hydroxy-tetrahydrocannabinol (11-OH-THC) and carboxy-tetrahydrocannabinol (THC-COOH). Currently, the techniques used to determine the presence of drugs (such as cannabinoids) require analysis of blood, plasma, urine or oral fluid samples. Most analytical techniques use gas chromatography coupled to mass spectrometry (GC / MS). This brings the problem of having to collect samples and bring them back to the laboratory for further analysis. These techniques have long analysis times, with most analyses taking more than 15 minutes to detect cannabinoids. In addition, the use of GC / MS to detect delta-9-THC also brings another problem because the ionization source is electron ionization (EI). Cannabidiol (CBD) is a resin extracted from the cannabis plant that has the same molecular weight as delta-9-THC and has the same mass spectrometry fragmentation pattern when ionized using electron ionization. Under the Controlled Substances Act, because CBD is a derivative of cannabis, it is classified as a Schedule I drug. However, the 2014 Farm Act allows the cultivation and sale of industrial hemp for market research purposes. Some states view this act as a legal right to sell CBD to agricultural contractors. This poses a challenge to quantifying the amount of delta-9-THC in a person's breath, as the signal could be the result of legally available CBD in a person's breath.

[0006] In some states, laws have been enacted that set legal limits for delta-9-THC in the body. Twelve states have a zero tolerance policy that states that no one should have any cannabinoids in their blood while driving. However, five states allow the use of medical marijuana. This leads to the problem of patients receiving treatment and then having to drive later in the day or later in the week because they may be considered to be driving under the influence of marijuana (DUIM). Analytical techniques that test for all three cannabinoids can be problematic because THC-COOH, which is not psychoactive, remains in the blood long after both delta-9-THC and 11-OH-THC remain in the blood. Even if no psychoactive effects are experienced, a person may fail a cannabinoid test. Other states have passed their own blood marijuana content (BCC) laws. These select states each have their own limits, with a total range of 1 nanogram of THC per milliliter of blood (ng / ml) to 5 ng / ml. If a driver's concentration is above these values, they are considered DUIM, with penalties similar to drunk driving. Unfortunately, devices that can accurately and quickly detect delta-9-THC concentrations have not yet been developed.

[0007] Detection of cannabinoids from a person's breath is needed to allow for non-invasive, rapid assays in the field. Previous cannabinoid breath assays date back to 1972, when colorimetry was used to detect marijuana in the breath of an impaired person. This test collected breath and used a series of reactions with quinone-4-haloimine, 2,6-dihaloquinone-4-haloimine, sodium hydroxide, and ammonia to determine if the breath sample turned blue or red. These colorimetric tests must be performed in large reaction vessels, have a wide range of colors to represent a positive result, and require at least 1 microgram of THC in the breath to produce a positive reaction. These tests are not able to quantify levels of delta-9-THC and cannot be used in the field.

[0008] Currently, there are three types of breathalyzers used in the field by local law enforcement: liquid chromatography coupled to mass spectrometry (LC / MS), high-field asymmetric waveform ion mobility spectrometry (FAIMS), and liquid chromatography coupled to mass spectrometry. The first company, Sensabues, uses a breath sampling kit. The person breathes into a sampling chamber and then sends the device back to the lab for analysis using LC / MS. Although this method can be used for quantification, it cannot be used in the field, which hinders this method. In addition, once the sample arrives at the lab, it takes several minutes for the LCMS to analyze the sample before cannabinoids can be seen. Two other companies offer systems that are capable of on-site measurements. Cannabix Technologies Inc. has partnered with the Yost research group at the University of Florida to create a portable breathalyzer for Δ-9-THC that utilizes high-field asymmetric waveform ion mobility spectrometry (FAIMS). The device can analyze samples within a two-minute time window and can detect and quantify Δ-9-THC at concentrations of 10 parts per million (ppm) in the sample. While this device overcomes the portability issue, FAIMS does not contain the same resolution or peak capacity required to determine delta-9-THC concentrations. Without the proper resolution, the instrument will not be able to distinguish between compounds in tobacco smoke and marijuana smoke. Additionally, without peak capacity, other compounds, such as illegal drugs, may be overlooked, allowing drivers to continue driving under the influence of different illegal substances. Another company, Hound Labs Inc., has developed a handheld instrument that also utilizes liquid chromatography coupled to spectroscopy to detect the presence of delta-9-THC by attaching a fluorescent adduct to the para position of the delta-9-THC molecule. The device requires only picogram quantities of delta-9-THC and works by capturing a person's breath and condensing the breath onto a C18 medium. The medium is then transported to a TLC plate where a solvent mixture is applied and after a few minutes a fluorescent marker is placed across the TLC plate. The fluorescent marker will bind specifically to the delta-9-THC, which is then excited using a diode-pumped solid-state laser. This excited state will cause a spectral shift and can be referenced to a known delta-9-THC sample. This method requires more than 8 minutes to analyze a sample and requires the use of a known reference material each time the analysis is performed.

[0009] Since the beginning of this century, the number of synthetic opioid overdoses in civilians has increased by 200%, and from 2014 to 2016, 50% of all drug overdoses were attributed to opioids. Opioid overdoses in military personnel have also increased, as military emergency departments recorded a steady increase from 27% to 42% of opioid overdoses between 2009 and 2012. With so many opioid overdoses occurring in both civilians and military personnel, improved detection methods are needed. Most drug enforcement agencies can only analyze opioids using gas chromatography coupled to mass spectrometry (GC / MS) or liquid chromatography coupled to mass spectrometry (LC / MS). Opioids, such as methadone and fentanyl, are immediately hydroxylated upon entering the body. This hydroxylation process begins a metabolic cycle that produces volatile organic compounds (VOCs), such as propionic acid. Previous methods for detecting these VOCs have featured solid phase microextraction (SPME) techniques coupled to GC / MS. Unfortunately, these methods require long equilibration times of up to 10 min. Summary of the invention

[0010] Disclosed are systems, devices, methods, and computer-readable storage media that provide techniques for improved on-site quantification of cannabinoids and other substances from a breath sample. Exemplary breath analysis systems and devices of the present invention may include a sampling chamber having an inlet configured to receive a breath sample and provide the breath sample to the sampling chamber. A molecule collector may be disposed in the sampling chamber. The molecule detector may be configured to cause volatile organic compounds (VOCs) present in a breath sample introduced into the sampling chamber to adhere to the molecule collector. The breath analysis system and device may include a heating element configured to introduce or cause heat in the sampling chamber, which may cause desorption of at least a portion of the VOCs attached to the molecule collector. Exemplary breath analysis systems and devices may include an analysis device configured to identify one or more target VOCs from at least a portion of the VOCs released from the molecule collector and generate an output representing the identified one or more target VOCs. The output may include information quantifying the concentration of the one or more target VOCs relative to the source of the breath sample provided to the sampling chamber. In these aspects, the analysis device may use a mass spectrometer or a terahertz (THz) spectrometer to identify the one or more target VOCs.

[0011] The foregoing has been quite broadly summarized the features and technical advantages of the present invention so that the following detailed description of the present invention can be better understood. The additional features and advantages of the present invention that constitute the subject matter of the claims of the present invention will be described below. It should be understood by those skilled in the art that the disclosed concepts and specific embodiments can be easily used as the basis for modifying or designing other structures for achieving the same purpose of the present invention. It should also be recognized by those skilled in the art that such equivalent constructions do not depart from the spirit and scope of the present invention as set forth in the appended claims. When considered in conjunction with the accompanying drawings, the novel features (in terms of its organization and method of operation, and further purposes and advantages) that are considered to be features of the present invention will be better understood from the following description. However, it should be clearly understood that each of the accompanying drawings is provided only for the purpose of illustration and description, and is not intended to be a definition of limitation of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS

[0012] For a more complete understanding of the present invention, reference is now made to the following description in conjunction with the accompanying drawings, in which:

[0013] Figure 1 A block diagram showing a system for analyzing a breath sample according to aspects of the present invention;

[0014] Figure 2 A diagram showing a mass spectrometer-based system for analyzing a breath sample according to aspects of the present invention;

[0015] Figure 3 A diagram showing a terahertz spectrometer-based system for analyzing a breath sample according to aspects of the present invention;

[0016] Figure 4A is a diagram illustrating aspects of receiving a breath sample in a system configured in accordance with aspects of the present invention;

[0017] Figure 4B is a diagram illustrating aspects of the behavior of breath sample molecules received in a system configured in accordance with aspects of the present invention;

[0018] Figure 4C is a diagram illustrating aspects of analyzing breath sample molecules using a mass spectrometer-based system configured in accordance with aspects of the present invention;

[0019] Figure 4D is a diagram illustrating aspects of analyzing breath sample molecules using a terahertz (THz) spectrometer-based system configured in accordance with aspects of the present invention;

[0020] Figure 5 is a graph showing observed VOCs of healthy breath samples;

[0021] Figure 6is a graph showing VOCs observed in breath samples of people with seasonal allergies;

[0022] Figure 7 is a graph showing VOCs observed in a breath sample of a person after using a mouthwash;

[0023] Figure 8 is a graph showing the observed VOCs of toluene, benzene, and xylenes;

[0024] Fig. 9 is a graph showing observed VOCs of a cannabis sample; and

[0025] Fig.10 is a flow chart of a method for analyzing a breath sample according to aspects of the present invention. DETAILED DESCRIPTION

[0026] Various features and advantageous details are more fully described with reference to the non-limiting embodiments shown in the accompanying drawings and described in detail in the following specification. Descriptions of well-known starting materials, processing techniques, parts and equipment are omitted so as not to unnecessarily obscure the details of the present invention. However, it should be understood that although the detailed description and specific examples illustrate embodiments of the present invention, they are given only for illustration and not for limitation. According to the present disclosure, various replacements, modifications, additions and / or rearrangements within the spirit and / or scope of the basic inventive concept will become apparent to those skilled in the art.

[0027] about Figure 1 , a block diagram of a system for analyzing a breath sample according to aspects of the present invention is shown as system 100. Figure 1As shown, the system 100 includes a sampling chamber 110 and an analysis device 120. In these aspects, the sampling chamber 110 can be configured as a removable and / or disposable component of the system 100. In this arrangement, the sampling chamber 110 can be removably connected to the analysis device 120. Configuring the sampling chamber 110 as a removable component of the system 100 can prevent contamination of continuous breath samples analyzed by the analysis device 120. For example, a first sampling chamber can be used to analyze a breath sample provided by a first person, and a second sampling chamber can be used to analyze a breath sample provided by a second person. Using different sampling chambers for different breath samples prevents one breath sample from potentially contaminating another breath sample. In the case where one or more sampling chambers 110 are configured as disposable components, the sampling chamber can be discarded after use or after a desired time (e.g., the time required for a law enforcement agency to keep the sampling chamber for evidence purposes, for example). In the case where one or more sampling chambers 110 are configured as reusable components, the sampling chamber 110 can be cleaned and prepared for subsequent reuse as needed. In these aspects, a portion of the analysis device 120 may also be configured as a disposable component and / or a reusable component, such as a portion of the analysis device 120 that may be contaminated if utilized to analyze multiple breath samples. In one aspect, the sampling chamber may be configured as a cartridge that may be used to obtain a breath sample and then placed within or connected to the sampling device 120 for analysis. For example, the analysis device 120 may be installed in a law enforcement vehicle, and law enforcement personnel may have a person suspected of being a DUIM provide a breath sample to the cartridge, which is then connected to the analysis device 120 to facilitate analysis according to various aspects of the present invention. It is noted that the exemplary configurations described above are provided for purposes of illustration and not limitation, and many other ways of arranging, connecting, and / or integrating components of a breath analysis system according to the present invention may be utilized.

[0028] like Figure 1 As shown, the sampling chamber 110 may include a housing having an outer surface 104 and an inner surface 106. The inner surface 106 of the housing may define a volume of the sampling chamber. An inlet 112 may be connected to the sampling chamber 110. The inlet 112 may be configured to receive a breath sample 102 and provide the breath sample 102 to the sampling chamber 110, and more specifically, to provide the breath sample 102 to the volume of the sampling chamber. In various aspects, the disposable mouthpiece (in Figure 1102) can be removably connected to a first end of the inlet 112, and a second end of the inlet 112 can be connected to the sampling chamber 110. Alternatively, the first end of the inlet 112 can be used as an interface tube, and the second end of the inlet 112 can be connected to the sampling chamber 110. The valve 113 can be disposed in the air flow path between the inlet 112 and the sampling chamber 110. The valve 113 can be configured in at least a first state and a second state. The first state can correspond to an open state configured to allow the breath sample 102 to flow into the sampling chamber 110, and the second state can correspond to a closed state configured to prevent contamination of the breath sample 102, for example, preventing ambient air from entering the sampling chamber 110 once the breath sample 102 is provided. In one aspect, the sampling chamber 110 may include an outlet configured to release non-VOCs from the sampling chamber 110, as described below with reference to Figure 4A The system 100 may also include a sensor 115 configured to determine whether the breath sample meets one or more criteria. For example, the sensor 115 may be configured to determine whether the breath sample 102 is applied with sufficient force, has sufficient volume, etc., which may ensure that the breath sample 102 is sufficient for facilitating analysis according to aspects of the present invention.

[0029] The molecule collector 116 may be disposed within the sampling chamber 110. At least a portion of the molecule collector 116 may be disposed within the volume of the sampling chamber 110. The molecule collector 116 may be configured to attach volatile organic compounds (VOCs) present in the breath sample. For example, the molecule collector 116 may be composed of, for example, material construction. Note that the molecule collector 116 may be formed of a single material (e.g., one of the above-mentioned materials), or may be formed of multiple materials (e.g., a base material that has been coated with one or more of the above-mentioned materials). In various aspects, the molecule collector 116 may have a solid form factor, such as a plate or rod formed from the above-mentioned materials, or may have another form factor, such as a grid formed from the above-mentioned materials. The sampling chamber 110 may also include a heating element 118 or be connected to the heating element 118, which is configured to introduce heat into the sampling chamber 110. For example, the heating element 118 may include a power supply that is connected to the molecule collector 116 and is configured to apply a voltage to the molecule collector 116. Applying a voltage to the molecule collector 116 may heat the molecule collector, thereby introducing heat into the sampling chamber 110. As described in more detail below, heat introduced into the sampling chamber 110 may cause VOCs attached to the molecule collector 116 to be released into the volume of the sampling chamber, thereby facilitating analysis and identification of one or more of the VOCs present in the sampling chamber 110 .

[0030] The system 100 may include an analysis device. The analysis device 120 may be configured to identify one or more target VOCs from the VOCs present in the sampling chamber 110 after at least a portion of the VOCs are released from the molecular collector 116 (e.g., due to heat provided or introduced by the heating element 118). In addition, the analysis device 120 may be configured to generate an output representative of the one or more target VOCs. Figure 1 As shown, the analysis device 120 may include one or more processors 122, a memory 130, an analysis component 124, and one or more input / output (I / O) devices 126. The memory 130 may store instructions 132 that, when executed by the one or more processors 122, cause the one or more processors 122 to control the operation of the analysis device 120 and possibly other components of the system 100 (e.g., the heating element 118) with respect to analyzing and identifying one or more target VOCs of the breath sample 102. The one or more target VOCs may include delta-9-tetrahydrocannabinol (delta-9-THC), a THC metabolite, an opioid, an opioid metabolite, or a combination thereof.

[0031] I / O devices 126 may include switches, buttons, lights, displays, or other control elements configured to receive inputs and / or provide outputs associated with the operation of system 100. For example, switches and / or buttons may be provided to power system 100 on and off, indicate that a breath sample has been provided, identify one or more target VOCs to be identified, or other functions and control features. Lights may be provided to indicate that system 100 is powered on and off, indicate whether the breath sample provided is satisfactory (e.g., based on information received from sensor 115), indicate the identified VOC (e.g., different lights may be associated with different VOCs that may be identified by system 100), or provide other information associated with the operation of system 100. One or more displays may additionally be provided to display information, such as indicating the identified VOC, indicating the operating status of system 100 (e.g., providing information indicating one or more of the different features described above with respect to the lights or other status information), etc. Analysis component 124 may include a mass spectrometer or a terahertz (THz) spectrometer configured to identify one or more target VOCs of breath sample 102 .

[0032] about Figure 2 , illustrates exemplary aspects of a system 100 utilizing a mass spectrometer-based analysis component. Note that Figure 1 and Figure 2 In the drawings, the same reference numerals are used to refer to similar parts. Figure 2As shown, the analysis component 124 may include an ionizer 222, a mass analyzer 224, and a detector 226. As described above, when the valve 113 is in an open state, the breath sample 102 may be provided to the inlet 112 through the mouthpiece 210. After the breath sample 102 is provided to the volume of the sampling chamber 110, the heating element 118 ( Figure 2 124). The outlet 204 may be used to provide the released VOCs to the analysis component 124. The valve 213 may be configured to be in a first state (e.g., an open state) and a second state (e.g., a closed state) to control the provision of VOCs to the analysis component. For example, in the first state, VOCs may be allowed to pass through the outlet 204 to the analysis component 124, and in the second state, VOCs may be prevented from passing through the outlet 204 to the analysis component 124. The ionizer 222 may be configured to ionize at least a portion of the VOCs released from the molecular collector to produce one or more ionized fragments. The mass analyzer 224 may be configured to separate the one or more ionized fragments (e.g., based on the mass-to-charge ratio of the one or more ionized fragments), and the detector 226 may be configured to identify one or more target VOCs based on the separated one or more ionized fragments. In one aspect, the mass spectrometer components (e.g., ionizer 222, mass analyzer 224, and detector 226) may operate under the control of or in conjunction with a computing device (e.g., a computing device including one or more processors 122, memory 130, and one or more I / O devices 126). For example, the computing device may receive information from the mass spectrometer components, such as information associated with one or more target VOCs identified in breath sample 102, and may generate output representing the one or more target VOCs based on the information associated with the one or more target VOCs. In addition, the computing device may be configured to display the output on an output device (e.g., a display device).

[0033] about Figure 3 , shows exemplary aspects of a system 100 utilizing an analytical component based on a THz spectrometer. Note that Figure 1 and Figure 3 In the drawings, the same reference numerals are used to refer to similar parts. Figure 2 As shown, the analysis component 124 may include an excitation source 320 and a detector 322. As described above, when the valve 113 is in an open state, the breath sample 102 may be provided to the inlet 112 through the mouthpiece 310. After the breath sample 102 is provided to the volume of the sampling chamber 110, the heating element 118 ( Figure 3324 is activated by the excitation source 320 (not shown), resulting in the desorption of the VOCs attached to the molecule collector 116. The excitation source 320 may be configured to introduce an excitation signal 324 into the sampling chamber after at least a portion of the VOCs are released from the molecule collector 116, and the detector 322 may be configured to identify one or more target VOCs based on one or more features associated with the excitation of at least a portion of the VOCs released from the molecule collector 116 in response to the excitation signal 324. In one aspect, the excitation source 320 may be a THz laser device, and the excitation signal 324 may be a THz laser signal. In various aspects, the one or more features associated with the excitation of at least a portion of the VOCs may include at least one of an absorption feature and a fluorescence emission feature, which may be used to identify one or more target VOCs present in the breath sample 102, as described in more detail below. In one aspect, the THz spectrometer components (e.g., the excitation source 320 and the detector 322) may be operated under the control of a computing device (e.g., a computing device including one or more processors 122, a memory 130, and one or more I / O devices 126) or in conjunction with the computing device. For example, the computing device may receive information from the THz spectrometer component (e.g., information associated with one or more target VOCs identified in the breath sample 102), and may generate an output representing the one or more target VOCs based on the information associated with the one or more target VOCs. In addition, the computing device may be configured to display the output on an output device (e.g., a display device).

[0034] Back to Figure 1 , the output representing the one or more target VOCs may include information quantifying the concentration of the one or more target VOCs relative to the source of the breath sample. This information may be helpful in determining whether the source of the breath sample (e.g., the person providing the breath sample 102) is compromised or otherwise affected by one or more substances (e.g., substances corresponding to the identified one or more target VOCs). By providing information quantifying the concentration of the one or more target VOCs, a more accurate determination may be made as to whether the source is compromised or otherwise affected by a substance. Additionally, techniques utilized by the system 100 (e.g., based on Figure 2 or Figure 3 The system 100 may help identify and quantify VOC levels more quickly, thereby facilitating on-site determination of whether a source is compromised or under the influence of one or more substances (e.g., THC). For example, unlike existing systems that can quantify certain VOCs (which take a long time to complete), the system 100 may help identify and quantify VOCs in seconds, thereby facilitating practical use in the field by, for example, law enforcement personnel.

[0035] about FIG. 4A to FIG. 4D , showing various aspects of a system for analyzing VOCs present in a breath sample according to various aspects of the present invention. Figure 4A As shown, a breath sample may be provided to sampling chamber 110 via inlet 112. The breath sample may include one or more VOCs, such as Figure 4A 404, 406, 408 are shown in FIG. 404. In addition, the breath sample may contain non-VOCs, which may contain other gases, such as CO2 402. In one aspect, the sampling chamber 110 may include an outlet 410 configured to release the non-VOCs from the sampling chamber 110. Note that the outlet 410 is not Figure 2 The exit 204 is different. Figure 4B As shown, VOCs 404, 406, 408 present in the breath sample may be attached to the molecule collector 116. Figure 4C In the embodiment, the heating element 118 (at FIG. 4A to FIG. 4D 10), which introduces heat into the sampling chamber 110, causing the VOC to be released from the molecular collector 116. After the VOC is released from the molecular collector 116, the VOC (or at least a portion of the VOC) can be discharged through the outlet 204 ( Figure 4C ) is provided to a mass spectrometer-based analysis device (e.g. Figure 2 The analytical device shown in FIG. 1 is used for analysis, as described above with reference to Figure 2 Described. Figure 4D In the embodiment, the heating element 118 (at FIG. 4A to FIG. 4D The VOC is released from the molecular collector 116 by activating the sample chamber 110 (not shown), introducing heat into the sample chamber 110, causing the VOC to be released from the molecular collector 116. After the VOC is released from the molecular collector 116, the VOC (or at least a portion of the VOC) can be provided to an analytical device based on a THz spectrometer (e.g. Figure 3 The analytical device shown in FIG. 1 is used for analysis, as described above with reference to Figure 2 For example, Figure 4D As shown, an excitation signal 324 may be provided or projected into the sampling chamber. As described below, the excitation of VOCs by the excitation signal 324 may be used by the detector 322 to identify one or more target VOCs present in a breath sample provided to the sampling chamber 110.

[0036] Note that systems based on THz spectrometers can provide multiple advantages over existing systems. For example, the use of THz spectrometers can facilitate rapid analysis of breath samples, which can be completed in seconds, and can facilitate portable systems that can be transported in local law enforcement vehicles. In addition, because the bonds in the molecules are different, systems based on THz spectrometers are able to distinguish between Δ-9-THC and CBD. THz spectrometers, or far-infrared spectrometers, can be used to identify compounds with dipoles that contain rotational motion. The spectral range is between the microwave and infrared regions, operating between 3mm and 30μm or 0.1THz-10 THz. Another advantage of systems based on THz spectrometers is that the particle size of identifiable compounds (such as VOCs). For example, THz time-domain spectrometers (THz-TDS) are able to detect compounds with concentrations as low as one trillionth. THz-TDS works by emitting a pulsed femtosecond laser (which can be a Ti:Sapphire laser). The laser is sent to two photoconductive antennas after being split in a delay line, generating a probe beam and a pump beam. The pump beam excites a nonlinear crystal that can be formed from gallium arsenide (GaAs) and focuses the signal into a sampling space (e.g., a volume in the sampling chamber 110). The probe beam sends the signal to a second photoconductive antenna, which detects the THz radiation. In order to obtain a spectrum of the sample, a blank must be taken before the sample to serve as a reference for extracting the sample from the THz spectrum. THz-TDS can be used to determine the torsional deformation of molecules and the intermolecular bonding of molecules. The benefit of analyzing gas phase compounds (e.g., breath) is that the intermolecular bonding interactions in the gas phase are weak, leaving only torsional and rotational spectral signals. One challenge with gas analysis faced by THz-TDS is the presence of large amounts of water in the atmosphere, which can change the accuracy of the device depending on the altitude of the device. This problem can be solved by collecting a background before analysis and using a vacuum or a dry inert gas (e.g., helium, which removes water from the signal).

[0037] The cannabinoid signal in the breath may be too low to be detected by THD-TDS, but a preconcentrator can be used to obtain a suitable signal. Previously, preconcentrators have been used to analyze Δ-9-THC using LC / MS. However, these preconcentrators use adsorbent capture materials, which retain water and impair the identification of volatile organic compounds (VOCs). To overcome this challenge, the above-mentioned molecular collector 116 can utilize carbon molecular sieves, which reduce the amount of water absorbed when looking for VOCs. Carbon molecular sieves work by trapping compounds between graphite planes so that molecules diffuse quickly or slowly depending on the size of the molecules. When a heating element is applied to the adsorbent material, the molecules can be quickly emitted as the graphite plane expands. As described above, in the system of the present invention, a conductive material formed by or coated with a carbon molecular sieve adsorbent material can be used as a molecular collector. However, depending on the type of adsorbent material, the material may release VOCs at different rates, so that separation can still be achieved. This desorption process distinguishes certain carbon molecular sieve materials from other materials in fast gas analysis technology. In various aspects, the molecular collector 116 can be composed of a VOC desorbing material (e.g. for example 1000))formed. Can be used in rapid VOC gas analysis to identify specific molecules based on emission time. Larger molecules may not emit from the graphite plane faster than smaller molecules, making smaller compounds desorb and analyze faster than larger molecules.

[0038] In the following description, similar to the above reference Figure 3 The system described herein is a THz spectrometer-based system for cannabinoid detection similar to the above referenced Figure 2 The system described was cross-referenced with a system based on a Thermo Fischer PolarisQ mass spectrometer. The sampling chamber of the molecular collector formed by the 1000 coated mesh is connected to a heating element (e.g., a 24 volt power supply). After opening the valve connecting the inlet and the replaceable mouthpiece to the sampling chamber, the person will exhale into the sampling chamber, capturing the VOCs in the Other VOCs also attach to the molecular collector, while non-VOC gases flow through and out of the sampling tube ( Figure 4A After exhalation is complete, close the valve to prevent any excess compounds from being deposited on the molecular collector ( Figure 4B ). Then, 24 volts is applied to the molecular collector to uniformly heat the molecular collector and promote the rapid desorption of the compounds attached thereto. For mass spectrometry reference characterization, the released compounds are provided to the mass spectrometer to detect the signal ( Figure 4C ).Depend on The resulting molecular collector also facilitates separation techniques where smaller VOCs emit faster than larger compounds. This enables the determination of the appropriate time to emit the cannabinoid from the molecular collector. Once the appropriate time is determined, a THz spectrometer is used to determine the presence of the cannabinoid in the absence of other background signals, thereby facilitating accurate and precise measurements. Once this subsample of the cannabinoid is collected, the sampling chamber is placed in a THz spectrometer-based analysis device whereby an excitation signal (e.g., a THz laser signal) is used to detect the sample (e.g., the THz laser signal) emitted from the molecular collector. Figure 4D ). A THz spectrometer-based system can function in two ways. The first is that the compound (e.g., VOC) can be emitted from a molecule collector and then excited by an excitation signal. The detector will then detect the absorbance of one or more excited molecules as they return to the ground state. Another mechanism is that the excitation of molecules due to rapid heating of the molecule collector can result in the emission of a fluorescence signal. The system can be configured to determine the presence of cannabinoids and / or other VOCs in a breath sample based on the fluorescence signal emitted in response to the excitation of the VOC by the excitation signal.

[0039] A mass spectrometer-based system was developed and used to analyze breath samples. Using this system, differences in the physical state of the person exhaling have been demonstrated. Breath samples from healthy people, people with seasonal allergies (anaphylactic breath), and breath samples obtained directly from people after gargling with Listerine were collected in a sampling chamber whose molecule collector consisted of a ion trap mass spectrometer connected to a PolarisQ. Coated mesh is made. Figure 5 (Healthy breath sample), Figure 6 (breath samples from people with seasonal allergies) and Figure 7 The results of the analysis performed on each breath sample are shown in (a breath sample obtained directly from a person after gargling with Listerine). Figure 5 In FIG. 5 , the cropped image 504 shows a magnified view of the peak shown in box 502. Figure 6 In FIG. 6 , the cropped image 604 shows a magnified view of the peak shown in box 602. Figure 7 In FIG. 7 , the cropped image 704 shows a magnified view of the peak shown in box 702. Figure 5 As shown in Figure 1, a large m / z value of 51.93 was observed, which corresponds to 1-butene-3-yne. This 1-butene-3-yne was not found in the allergic breath samples. In the allergic breath samples, as Figure 6 As shown, the maximum peak was observed at 66.93 m / z (corresponding to isoprene), followed by a peak at 80.93 m / s (1-methyl-pyrrole) and a peak at 94.93 m / z (2-ethylpyrrole). Figure 7As shown, the peak associated with isoprene is reduced as expected, and other peaks are established, such as the ethyl methyl sulfide peak at 76.93 m / z and the 1,2,3-propanetriol peak at 90.93 m / z. In addition, larger molecular weight compounds appear, such as the octadecane peak at 254.60 m / z shown in the sheared image 604. These samples all show a significant 66.93 m / z peak, which is indicative of isoprene. Isoprene should be found in all breath samples and can be used as a reference to ensure that the instrument is sampling breath VOCs. As shown in FIG. Figures 5 to 7 As shown, significant changes in the observed compounds were found in the three different cases presented. As described below, the determination of cannabinoids in breath samples was achieved using terahertz spectroscopy using this instrument as a reference.

[0040] Terahertz spectra of benzene, toluene, and xylene were acquired and compared with those of gas samples from heated cannabis leaves using a MenloSystem (Martinsried, Germany) K15 time-domain terahertz spectrometer. The instrument was used to pump dry gas (helium) into the flask, forcing the volatile vapors out and into a sampling chamber where the VOCs attach to a carbon-based A voltage is then applied to the molecular collector to release the VOCs. The results for benzene, toluene, and xylene are shown in Figure 8 , where line 802 represents VOCs generated from xylene, line 804 represents VOCs generated from toluene, and line 806 represents VOCs generated from benzene. Fig. 9 Shown are the VOCs observed from a cannabis sample. Analysis of the gaseous sample allows for the acquisition of a rotational spectrum, explaining the low signal obtained for benzene at any scan frequency. The cannabis sample produces the highest number of rotated bonds, which is expected since this sample is not a pure sample. Xylenes and toluene appear to be the same peak, but xylenes consistently result in a lower frequency peak, while toluene appears at a higher frequency. This is because xylenes have two methyl groups attached to the aromatic ring, while toluene has only one methyl group attached to the aromatic ring.

[0041] Gas quantification methods based on THz spectroscopy have been done using cigarette smoke, using continuous wave THz spectroscopy. However, doing so requires a database to enter the variables of the Lorentz fit equation. Cannabinoids have not yet been databased, which makes the Lorentz fit equation unusable for cannabinoid quantification. However, quantification can still be achieved using the absorption coefficient of THz spectroscopy. Based on the comparison of the transmittance of the sample THz field with the transmittance of the measured transmission field, t(f), the absorption coefficient can be calculated as:

[0042]

[0043] Where ns(f) is the refractive index of the sample, c is the speed of light in a vacuum, φ(f) is the phase difference between the transmittance of the sample terahertz field and the transmittance of the reference terahertz field, f is the frequency, and d is the sample thickness. The sample thickness can be the length of the sampling chamber, which is 9 cm in the above example. The sample refractive index is expressed as:

[0044]

[0045]

[0046] The absorption coefficient α(f) can be calculated where the signal loss at the interface is equal to RL. The sample spectrum is subtracted from the reference spectrum so that the Beer-Lambert law is used as follows:

[0047]

[0048] Where T(f) is equal to the ratio of the intensity of the sample transmitted THz field to the intensity of the reference transmitted THz field. This can allow for rapid quantification of delta-9-THC. A breath sample analyzer system according to the present invention can be configured (e.g., via software stored as instructions) to calculate the concentration of cannabinoids from a person's breath using these equations. The sample size can vary from person to person. Thus, the system can be configured to take into account the total volume of the breath sample exhaled by the person in order to avoid or reduce inaccuracies in the determined concentration.

[0049] about Fig.10 , a flow chart of a method for analyzing a breath sample according to aspects of the present invention is shown as method 1000. In one aspect, method 1000 may be performed by Figure 1 The system 100 of , which can utilize a mass spectrometer-based method (as described above with reference to Figure 2 ), or a THz spectrometer-based method (as described above in reference Figure 3 In one aspect, the operations or steps of method 100 may be implemented as programs or instructions (e.g., Figures 1 to 3 Instructions 132), which are stored in a memory (e.g., Figures 1 to 3 130), when the instruction is executed by one or more processors (e.g., Figures 1 to 3 When executed by one or more processors 122), the one or more processors are caused to perform operations for analyzing a breath sample according to aspects of the present invention.

[0050] like Fig.10 As shown, method 1000 includes step 1010, receiving a breath sample in a sampling chamber. As described above, a breath sample can be received through an inlet (e.g., Figure 1 The breath sample is received in the sampling chamber by an inlet 112 connected to the sampling chamber (e.g., Figure 1The sampling chamber 110 may include a molecule collector (e.g., Figure 1 In step 1020, method 1000 includes introducing heat into the sampling chamber via a heating element. In one aspect, the Figure 1 The method 1000 includes, at step 1030, identifying one or more target VOCs from the VOCs present in the sampling chamber by an analysis device after at least a portion of the VOCs are released from the molecular collector. As described above, at least a portion of the VOCs may be released from the molecular collector by heat introduced into the sampling chamber by the heating element (e.g., at step 1020). The analysis device may be a mass spectrometer-based device (e.g., as described above with reference to Figure 2 ), or may be a THz spectrometer-based device (as described above with reference to Figure 3 ). At step 1040, method 1000 includes generating, by an analysis device, an output representing one or more target VOCs. In one aspect, the one or more target VOCs may be associated with one or more of Δ-9-THC, 11-hydroxy-tetrahydrocannabinol (11-OH-THC), carboxy-tetrahydrocannabinol (THC-COOH), THC metabolites, opioids (e.g., methadone and fentanyl, opioid metabolites). As described above, the output representing the one or more target VOCs may include information quantifying the concentration of the one or more target VOCs relative to a source of the breath sample (e.g., a person providing the breath sample).

[0051] As shown above, the breath analysis system and method according to the present invention can provide a device that helps detect cannabinoids and other substances from breath samples on the scene. Law enforcement officers can use this system to quickly and accurately identify / determine whether the driver is a DUIM. The ability to make such a determination on the scene greatly enhances the ability of the criminal justice field in detecting and solving this problem. For example, previous technologies require obtaining samples and then sending them to the laboratory, which takes several minutes or hours. Such a long analysis time makes it impossible to take any measures properly at the scene of the incident. On the contrary, using the breath analysis system according to the present invention, local law enforcement officers can obtain solid evidence on the scene. The application of this instrument challenges other fields, hoping to move towards further detecting DUIM drivers, removing them from the road, and improving the safety of other drivers. In addition, the breath analysis system of the present invention can help detect other illegal drugs using fast and portable technology. In addition to on-site detection, the ability to accurately quantify cannabinoid concentrations provided by the disclosed system can also provide the ability to develop standard concentrations for defining whether a person is a DUIM.

[0052] Although the embodiments of the present application and their advantages have been described in detail, it should be understood that various changes, substitutions and modifications can be made herein without departing from the spirit and scope of the present invention as defined by the appended claims. Moreover, the scope of the present application is not intended to be limited to the specific embodiments of the processes, machines, manufactures, material compositions, means, methods and steps described in the specification. As those of ordinary skill in the art will easily understand from the disclosure of the present invention, the processes, machines, manufactures, material compositions, means, methods or steps that currently exist or will be developed to perform functions substantially the same as the corresponding embodiments described herein or to achieve results substantially the same as the corresponding embodiments described herein can be utilized according to the present invention. Therefore, the appended claims are intended to include these processes, machines, manufactures, material compositions, means, methods or steps within their scope. Moreover, the scope of the present application is not intended to be limited to the specific embodiments of the processes, machines, manufactures, material compositions, means, methods and steps described in the specification.

Claims

1. A system for analyzing a breath sample, the system comprising: Sampling room; an inlet connected to the sampling chamber and configured to receive a breath sample containing volatile organic compounds and provide the breath sample to the sampling chamber; a molecule collector disposed within the sampling chamber, wherein the molecule collector is configured to attach volatile organic compounds present in the breath sample; a heating element configured to introduce heat into the sampling chamber; A mass spectrometer, the mass spectrometer being configured to: identifying one or more target volatile organic compounds from the volatile organic compounds present in the sampling chamber after releasing at least a portion of the volatile organic compounds from the molecular collector by heat introduced into the sampling chamber by the heating element; and outputting information representative of the one or more target volatile organic compounds; A computing device communicatively connected to the mass spectrometer, wherein the computing device includes one or more processors and a memory communicatively connected to the one or more processors, the one or more processors being configured to: generating information quantifying the concentration of each of the one or more target volatile organic compounds based on the information output by the mass spectrometer; and an output device communicatively connected to the computing device, wherein: The mass spectrometer comprises: an ionizer configured to ionize at least a portion of the volatile organic compounds released from the molecular collector to produce one or more ionized fragments; a mass analyzer configured to separate the one or more ionized fragments; and a detector configured to identify the one or more target volatile organic compounds based on the separated one or more ionized fragments; and The one or more processors are configured to: displaying the output on the output device, The one or more characteristics associated with excitation of at least a portion of the volatile organic compounds include at least one of: an absorption characteristic and a fluorescence emission characteristic.

2. The system according to claim 1, wherein: The molecule collector comprises Coated grid.

3. The system according to claim 1, wherein: The heating element includes a power source connected to the molecule collector and configured to apply a voltage to the molecule collector to introduce heat into the sampling chamber.

4. The system according to claim 1, wherein: The one or more target volatile organic compounds include delta-9-THC, a THC metabolite, an opioid, an opioid metabolite, or a combination thereof.

5. The system of claim 1, further comprising a disposable mouthpiece removably connected to the first end of the inlet, wherein A second end of the inlet is connected to the sampling chamber.

6. The system of claim 1, further comprising a valve disposed in an air flow path between the inlet and the sampling chamber, wherein: The valve is configured in at least a first state and a second state, the first state corresponding to an open state, the open state configured to allow the breath sample to flow into the sampling chamber, and the second state corresponding to a closed state configured to prevent contamination of the breath sample.

7. The system of claim 1, further comprising an outlet configured to release non-target volatile organic compounds from the sampling chamber.

8. The system according to claim 1, wherein: The one or more target volatile organic compounds include delta-9-THC, and the information quantifying the concentration of each of the one or more target volatile organic compounds includes the concentration of delta-9-THC present in the breath sample source.

9. The system of claim 1, further comprising a sensor configured to determine whether the breath sample meets one or more criteria.

10. A method for analyzing a breath sample, the method comprising: receiving a breath sample containing volatile organic compounds in a sampling chamber through an inlet connected to the sampling chamber, wherein the sampling chamber includes a molecule collector disposed within the sampling chamber, and wherein the molecule collector is configured to attach volatile organic compounds present in the breath sample; introducing heat into the sampling chamber via a heating element; identifying one or more target volatile organic compounds from the volatile organic compounds present in the sampling chamber by a mass spectrometer after releasing at least a portion of the volatile organic compounds from the molecular collector, wherein at least a portion of the volatile organic compounds are released from the molecular collector by heat introduced into the sampling chamber by the heating element; outputting, by the mass spectrometer, information representative of the one or more target volatile organic compounds identified by the mass spectrometer; generating, by one or more processors, information quantifying a concentration of each of the one or more target volatile organic compounds based on information representative of the one or more target volatile organic compounds output by the mass spectrometer; ionizing at least a portion of the volatile organic compounds released from the molecular collector by an ionizer of the mass spectrometer to produce one or more ionized fragments; separating the one or more ionized fragments by a mass analyzer of the mass spectrometer; identifying, by a detector of the mass spectrometer, the one or more target volatile organic compounds based on the separated one or more ionized fragments, wherein generating, by a computing device communicatively coupled to the mass spectrometer, an output representative of the one or more target volatile organic compounds based on information associated with the one or more target volatile organic compounds identified by the detector; and displaying the output on an output device, The one or more characteristics associated with excitation of at least a portion of the volatile organic compounds include at least one of: an absorption characteristic and a fluorescence emission characteristic.

11. The method according to claim 10, wherein: The molecule collector comprises The coated grid, wherein the heating element comprises a power source connected to the molecule collector, and wherein the method comprises applying a voltage to the molecule collector to introduce heat into the sampling chamber.

12. The method according to claim 10, wherein: The one or more target volatile organic compounds include delta-9-THC, a THC metabolite, an opioid, an opioid metabolite, or a combination thereof.

13. A non-transitory computer-readable storage medium storing instructions that, when executed by one or more processors, cause the one or more processors to perform operations for analyzing a breath sample, the operations comprising: activating a heating element configured to introduce heat into the sampling chamber after providing a breath sample comprising volatile organic compounds to the sampling chamber, wherein the sampling chamber comprises a molecule collector disposed within the sampling chamber, and wherein the molecule collector is configured to attach volatile organic compounds present in the breath sample; identifying one or more target volatile organic compounds from the volatile organic compounds present in the sampling chamber using a mass spectrometer after releasing at least a portion of the volatile organic compounds from the molecular collector, wherein at least a portion of the volatile organic compounds are released from the molecular collector by heat introduced into the sampling chamber by the heating element, and wherein the one or more target volatile organic compounds include delta-9-THC, a THC metabolite, an opioid, an opioid metabolite, or a combination thereof; outputting, by the mass spectrometer, information representative of the one or more target volatile organic compounds identified by the mass spectrometer; generating information quantifying a concentration of each of the one or more target volatile organic compounds based on information representative of the one or more target volatile organic compounds output by the mass spectrometer; ionizing at least a portion of the volatile organic compounds released from the molecular collector by an ionizer of the mass spectrometer to produce one or more ionized fragments; separating the one or more ionized fragments by a mass analyzer of the mass spectrometer; identifying, by a detector of the mass spectrometer, the one or more target volatile organic compounds based on the separated one or more ionized fragments, wherein generating, by a computing device communicatively coupled to the mass spectrometer, an output representative of the one or more target volatile organic compounds based on information associated with the one or more target volatile organic compounds identified by the detector; and displaying the output on an output device, The one or more characteristics associated with excitation of at least a portion of the volatile organic compounds include at least one of: an absorption characteristic and a fluorescence emission characteristic.